Skip to main content
STOP360
Menu
Overview
This study
Study treatment
Study activities
Benefits and risks
Your decision
Detailed Information
Schedule
Study activity details
Benefits
Risks
Payment
Privacy
Future research
Contact
Download PDF
This study
We want to improve how we treat
pulmonary exacerbations
from
Pseudomonas
.
Doctors usually treat this with two antibiotics together:
Aminoglycosides, such as tobramycin, are a type of antibiotic that may cause kidney injury, hearing loss, or balance issues.
Beta-lactams, such as ceftazidime, are a different type of antibiotic that do not cause these specific problems.
Now the cystic fibrosis community wants to know:
Can beta-lactams alone treat the exacerbation without the added risks of aminoglycosides?
We are doing this research study to answer that question.
Back
Next
Download PDF
Text-to-speech
00:00
/
00:00
x
Term
Close modal
Definition